Results     18-May-23
Announcements
Zydus Lifesciences consolidated net profit declines 25.36% in the March 2023 quarter
Sales rise 29.68% to Rs 4852.50 crore
Net profit of Zydus Lifesciences declined 25.36% to Rs 296.60 crore in the quarter ended March 2023 as against Rs 397.40 crore during the previous quarter ended March 2022. Sales rose 29.68% to Rs 4852.50 crore in the quarter ended March 2023 as against Rs 3741.80 crore during the previous quarter ended March 2022.

For the full year,net profit declined 56.31% to Rs 1960.30 crore in the year ended March 2023 as against Rs 4487.30 crore during the previous year ended March 2022. Sales rose 13.83% to Rs 16877.80 crore in the year ended March 2023 as against Rs 14827.60 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
 Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales4852.503741.80 30 16877.8014827.60 14
OPM %25.8819.18 -22.8722.53 -
PBDT1265.70758.30 67 3916.603438.40 14
PBT1087.10572.90 90 3193.902725.40 17
NP296.60397.40 -25 1960.304487.30 -56

Previous News
  Zydus Lifesciences to hold AGM
 ( Corporate News - 17-May-24   17:45 )
  Zydus Life jumps on USFDA nod for BP lowering drug
 ( Hot Pursuit - 04-Jul-24   16:28 )
  Barometers trade higher; Pharma shares advance; Biocon rallies over 3%
 ( Market Commentary - Mid-Session 28-Mar-24   12:32 )
  Zydus Lifesciences consolidated net profit rises 298.62% in the March 2024 quarter
 ( Results - Announcements 17-May-24   16:25 )
  Zydus Lifesciences receives USFDA approval for Azilsartan Medoxomil Tablets
 ( Corporate News - 04-Jul-24   14:54 )
  Zydus Life launches cancer drug in India
 ( Hot Pursuit - 13-Mar-24   16:06 )
  Zydus Lifesciences Ltd drops for fifth straight session
 ( Hot Pursuit - 27-Jun-24   13:35 )
  Zydus Life Ahmedabad facility gets 4 USFDA observations
 ( Hot Pursuit - 28-Mar-24   11:03 )
  Zydus and Guardant Health sign co-marketing agreement to promote Guardant360® portfolio for precision oncology
 ( Corporate News - 02-Nov-23   13:03 )
  Board of Zydus Lifesciences recommends Final Dividend
 ( Corporate News - 17-May-24   16:18 )
  Zydus Lifesciences launches cancer drug - IBYRA in India
 ( Corporate News - 13-Mar-24   16:31 )
Other Stories
  Emerald Finance consolidated net profit rises 98.84% in the June 2024 quarter
  05-Jul-24   15:52
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
Back Top